Clinical Surgical Oncology最新文献

{"title":"Faster postoperative recovery by robotic-assisted surgery in elderly patients with sigmoid colon and rectal cancer","authors":"Pingping Xu ,&nbsp;Yang Lv ,&nbsp;Zhengchuan Niu ,&nbsp;Qi Lin ,&nbsp;Dexiang Zhu ,&nbsp;Ye Wei ,&nbsp;Jianmin Xu","doi":"10.1016/j.cson.2022.100007","DOIUrl":"10.1016/j.cson.2022.100007","url":null,"abstract":"<div><h3>Background</h3><p>Currently, no published studies have compared the short-term and long-term outcomes of robotic-assisted and open surgery for elderly patients (aged 65 years or older) with sigmoid colon and rectal cancer in China. Hence, our study was conducted to assess whether robotic-assisted surgery is superior to traditional approaches.</p></div><div><h3>Methods</h3><p>A total of 208 patients who received either open resection (n ​= ​93) or robotic-assisted resection (n ​= ​115) between October 2010 and October 2014 were included in the study. We compared clinical characteristic variables and patient demographics between the two approaches and assessed short- and long-term outcomes.</p></div><div><h3>Results</h3><p>Patient characteristics were not significantly different between the groups. First flatus postoperative days (<em>P ​&lt;</em> .001), less time to liquid diet (<em>P</em> ​= ​.004), and shorter postoperative hospital stay (<em>P</em> ​= ​.046) were found in the robotic-assisted surgery group. The operation time was also more in the robotic-assisted surgery group (<em>P</em> ​= ​.03). The 3-year overall survival rate was 83.0% in the robotic-assisted surgery group and 78.0% in the open surgery group (<em>P</em> ​= ​.938). The 3-year disease free survival rate was 76.0% and 72.0% in the robotic-assisted surgery and open surgery groups, respectively (<em>P</em> ​= ​.817). No significant difference was found in the overall survival and disease-free survival between the two approaches.</p></div><div><h3>Conclusions</h3><p>Robotic-assisted surgery is safe and feasible for elderly patients with sigmoid colon and rectal cancer and is associated with more operation time and faster recovery as compared to open surgery. No significant differences were found in 3-year survival outcomes between the two groups.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"1 1","pages":"Article 100007"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X22000071/pdfft?md5=be131bac9967df876a87cc7f314a5e18&pid=1-s2.0-S2773160X22000071-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72975350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of low molecular weight heparin on bleeding after radical gastrectomy: A retrospective study from a high-volume center in China","authors":"Peng Zhou ,&nbsp;Yan Hu ,&nbsp;Peili Jin ,&nbsp;Jinxin Zheng ,&nbsp;Fenglin Liu ,&nbsp;Zhenbin Shen ,&nbsp;Weidong Chen ,&nbsp;Kuntang Shen ,&nbsp;Zhaoqing Tang ,&nbsp;Yihong Sun ,&nbsp;Xuefei Wang","doi":"10.1016/j.cson.2022.100003","DOIUrl":"10.1016/j.cson.2022.100003","url":null,"abstract":"<div><h3>Background</h3><p>Although low molecular weight heparin (LMWH) is recommended to prevent venous thromboembolism (VTE) in patients with gastric cancer, it's difficult for surgeons to choose appropriate time to start anti-coagulation because of the risk of surgical field bleeding after radical gastrectomy. We compared the risk of VTE and bleeding between patients receiving LMWH within and beyond 48 ​h after surgery.</p></div><div><h3>Methods</h3><p>The medical records of consecutive cases receiving radical gastrectomy from November 1st, 2017 to October 31st, 2018 in Zhongshan Hospital Gastric Cancer Center were carefully reviewed. Patients receiving LMWH within and beyond 48 ​h after surgery were regarded as Early Group (EG) and Delayed Group (DG), respectively. Incidence of VTE and bleeding complications were compared and risk factors of bleeding were evaluated.</p></div><div><h3>Results</h3><p>Six hundred and sixty-five cases were enrolled, including 465 in EG and 200 in DG. No significant differences of clinicopathological or operative features were observed except for fewer combined resection (DG: 5.0%, EG: 1.9%, P ​= ​0.030) and shorter surgery duration (DG: 194min, EG: 168min, P ​&lt; ​0.001). No patients suffered from deep venous thrombosis or pulmonary embolism in our study. However, postoperative bleeding rate was higher in EG (DG: 1.5%, EG: 7.5%, P ​= ​0.002). Multivariate analysis suggested that EG was the independent risk factor of bleeding (OR: 3.744, 1.13–12.36, P ​= ​0.030).</p></div><div><h3>Conclusion</h3><p>Use of LMWH 48 ​h after radical gastrectomy maybe a good choice for clinical surgeons to reduce postoperative bleeding rate without increasing VTE risk in gastric cancer patients.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"1 1","pages":"Article 100003"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X22000034/pdfft?md5=645f69d4f1cb432cec6ca807494e5ab3&pid=1-s2.0-S2773160X22000034-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83506953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Future trends in surgical oncology","authors":"Tibor Kovacs","doi":"10.1016/j.cson.2022.100006","DOIUrl":"10.1016/j.cson.2022.100006","url":null,"abstract":"","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"1 1","pages":"Article 100006"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X2200006X/pdfft?md5=b00434ffd6934811324b3cf1cae9afb1&pid=1-s2.0-S2773160X2200006X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79959872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can primary retroperitoneal sarcoma benefit from aggressive resection when it is smaller than a baseball? ——A propensity score-matched analysis","authors":"Aobo Zhuang ,&nbsp;Qian Wu ,&nbsp;Fuan Xie ,&nbsp;Jialiang Zheng ,&nbsp;Geng Zhang ,&nbsp;Weiqi Lu ,&nbsp;Yuhong Zhou ,&nbsp;Hanxing Tong ,&nbsp;Yong Zhang","doi":"10.1016/j.cson.2022.100002","DOIUrl":"10.1016/j.cson.2022.100002","url":null,"abstract":"<div><h3>Background and objectives</h3><p>Multivisceral resection (MVR) is advocated by some high-volume sarcoma centers. The objective of this study was to investigate the therapeutic effect of MVR in primary retroperitoneal sarcoma (RPS) with tumor burden less than 10 ​cm.</p></div><div><h3>Methods</h3><p>A retrospective analysis of patients with primary RPS who underwent radical surgical resection from 2009 to 2021 with lesions smaller than the size of a baseball (10 ​cm) was carried out. The incidence of postoperative morbidity and postoperative local recurrence-free survival rate of the MVR group and the non-MVR group were compared by propensity score-matching analysis.</p></div><div><h3>Results</h3><p>A total of 319 patients with primary RPS underwent surgical resection, of which 95 patients (29.8%) had a tumor burden less than 10 ​cm, with 24 patients (25.3%) involved in the MVR group and 71 patients (74.7%) in the non-MVR group. After matching, the two groups showed no statistical difference at baseline, while the MVR group reported more postoperative complications (P ​= ​0.008) and a longer median postoperative hospital stay (P ​= ​0.002). In terms of local recurrence-free survival, there were no statistical difference between the two groups (P ​= ​0.269).</p></div><div><h3>Conclusions</h3><p>Primary RPS patients with tumors smaller than baseball may not benefit from aggressive surgical strategy.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"1 1","pages":"Article 100002"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X22000022/pdfft?md5=8f303aaa5be271d65dad3f2bf06050b9&pid=1-s2.0-S2773160X22000022-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83035664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Short-term home remote monitoring of patients after lung cancer surgery","authors":"Wentao Fu,&nbsp;Dongfang Tang,&nbsp;Fuzhi Yang,&nbsp;Jing Wang,&nbsp;Yingting Wu,&nbsp;Xiaoyong Shen,&nbsp;Wen Gao","doi":"10.1016/j.cson.2022.100004","DOIUrl":"10.1016/j.cson.2022.100004","url":null,"abstract":"<div><p>Lung cancer remains the most common malignant tumor worldwide, accounting for the majority of cancer-related deaths. The main treatment for lung cancer is surgery. For patients with lung cancer who undergo surgical treatment, the current hospitalization time is short, and postoperative complications and the readmission and mortality rates are significantly higher. Therefore, to allow patients to better recover and monitor changes in their health conditions, remote monitoring might be a suitable approach. Several studies have shown that remote monitoring at home could be highly valuable in a wide range of surgical patients, and the application is practically feasible. Compared to traditional follow-up methods, the new technology can enable to understand the changes in patients’ conditions more comprehensively and relay the information instantly to the physicians and researchers. Hence, it is necessary to promote the application of this technology in patients with lung cancer surgery for improved outcomes in long-term follow-up.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"1 1","pages":"Article 100004"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2773160X22000046/pdfft?md5=b4c079869efdf80e10a8066750f6113b&pid=1-s2.0-S2773160X22000046-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77636010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}